| | Pathway ID | Pathway | Corrected value | Gene count | Annotated genes |
| | KEGG:hsa04151 | PI3K-Akt signaling pathway | 2.34-13 | 9 | AKT1, CDK2, CDK6, EGFR, GSK3B, IGF1R, KDR, MET, PTK2 | | KEGG:hsa05200 | Pathways in cancer | 8.86-13 | 9 | AKT1, CDK2, CDK6, DAPK1, EGFR, GSK3B, IGF1R, MET, PTK2 | | KEGG:hsa04510 | Focal adhesion | 5.02-13 | 8 | AKT1, EGFR, GSK3B, IGF1R, KDR, MET, PTK2, SRC | | KEGG:hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.51-13 | 7 | AKT1, EGFR, GSK3B, IGF1R, KDR, MET, SRC | | KEGG:hsa05205 | Proteoglycans in cancer | 1.30-10 | 7 | AKT1, EGFR, IGF1R, KDR, MET, PTK2, SRC | | KEGG:hsa04015 | Rap1 signaling pathway | 2.71-08 | 6 | AKT1, EGFR, IGF1R, KDR, MET, SRC | | KEGG:hsa04012 | ErbB signaling pathway | 3.76-08 | 5 | AKT1, EGFR, GSK3B, PTK2, SRC | | KEGG:hsa04068 | FoxO signaling pathway | 3.31-07 | 5 | AKT1, CDK2, EGFR, IGF1R, PLK1 | | KEGG:hsa04014 | Ras signaling pathway | 5.04-06 | 5 | AKT1, EGFR, IGF1R, KDR, MET | | KEGG:hsa04144 | Endocytosis | 9.94-06 | 5 | EGFR, IGF1R, KDR, MET, SRC |
|
|
